Liposuction Surgery Devices Global Market Report 2024

Liposuction surgery involves the extraction of fat from a specific body area through suction, aiming to eliminate excess body fat using diverse technologies.

Various technologies are employed in liposuction surgery devices, encompassing ultrasound-assisted liposuction (UAL), twin cannula-assisted liposuction (TCAL), laser-assisted liposuction (LAL), power-assisted liposuction (PAL), suction-assisted liposuction (SAL), tumescent liposuction, RF-assisted liposuction (RFAL), water-assisted liposuction (WAL), and aspirator devices. Ultrasound-assisted liposuction (UAL) utilizes ultrasonic energy for precise tissue lipolysis, emulsifying fat to facilitate its removal, especially in areas with abundant fat cells or deposits such as the chin, neck, cheeks, knees, calves, and ankles. Liposuction surgery devices come in two types: standalone and portable, finding applications in hospitals, ambulatory surgical centers, and cosmetic surgical centers.

The liposuction surgery devices market research report is one of a series of new reports that provides liposuction surgery devices market statistics, including liposuction surgery devices industry global market size, regional shares, competitors with a liposuction surgery devices market share, detailed liposuction surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the liposuction surgery devices industry. This liposuction surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liposuction surgery devices market size has grown rapidly in recent years. It will grow from $1.74 billion in 2023 to $2 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The rise in the historical period can be credited to factors such as the obesity epidemic, expansion in medical tourism, regulatory approvals, a growing aging population, and shifts in lifestyle.

The liposuction surgery devices market size is expected to see rapid growth in the next few years. It will grow to $3.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The anticipated growth in the forecast period is linked to an increase in disposable income, heightened patient awareness, the utilization of genetic testing, the embrace of personalized aesthetics, and the surge in telemedicine consultations. Key trends in the forecast period encompass a preference for non-invasive liposuction, laser and radiofrequency lipolysis, ultrasound-assisted liposuction, the integration of regenerative medicine, and the demand for customized body contouring.

The growth of the liposuction surgery devices market is significantly influenced by the increasing beauty consciousness among a large population and a rising demand for liposuction procedures by both men and women. The dissatisfaction with undesirable body fat often leads to psychological problems, prompting individuals to opt for liposuction surgery as an immediate solution without relying on diets or exercise. According to a report published by The Aesthetic Society on aesthetic plastic surgery statistics in April 2022, the overall surgical procedures increased by 54% in 2021 compared to 2020. Body surgery procedures also witnessed a notable rise, reaching 921,664 in 2021 from 564,303 in 2020, indicating a 63% increase. The growing beauty consciousness among the population is expected to drive the demand for liposuction surgery devices during the forecast period.

The growth of the liposuction surgery devices market is further propelled by the rising prevalence of obesity. Obesity, characterized by excess body fat accumulation, is a medical condition influenced by genetic, environmental, and lifestyle factors. Liposuction surgery devices play a crucial role in addressing obesity by surgically removing excess body fat from targeted areas, facilitating immediate fat reduction. According to the World Health Organization (WHO), 650 million adults, 340 million teenagers, and 39 million children are projected to be obese. The WHO predicts a continued rise in these numbers, with an estimate that by 2025, 167 million adults and children will become overweight or obese. This escalating obesity prevalence is a key driver for the growth of the liposuction surgery devices market.

A prominent trend in the liposuction surgery devices market is the integration of technological advancements in skincare. Traditional fat suctioning processes are being enhanced with the incorporation of various cutting-edge technologies, including non-invasive, power, laser, ultrasound, RF, and others, to improve liposuction outcomes, including skin form and texture. In January 2022, InMode, an Israel-based provider of innovative medical technologies, launched EVOLVE and EVOLVE, representing advanced hands-free non-invasive thermal body and skin treatments, as well as an all-in-one hands-free facial reshaping equipment.

Major companies in the liposuction surgery devices market are focusing on product innovation to enhance patient outcomes and expand their market presence. One notable innovation is the development of fat reduction systems, which utilize non-surgical or minimally invasive technologies to reduce fat cells in the body. In January 2021, Allergan Aesthetics launched the CoolSculpting Elite, a next-generation fat reduction system with applicators designed to complement the body's natural curves. This system harnesses proven CoolSculpting technology to target, freeze, and eliminate treated fat cells, and it is FDA-cleared to treat visible fat bulges in various areas of the body.

In April 2022, Symeres, a Netherlands-based drug discovery services firm, acquired Organix to expand its drug discovery business into the lipids market. Organix, a US-based manufacturer of lipids and organic chemistry contractors, aligns with Symeres' strategy to address the growing demand from developers of mRNA therapeutics and vaccines.

Major companies operating in the liposuction surgery devices market include Solta Medical Inc., Cynosure LLC, Invasix Inc., Alma Lasers Ltd., Yolo Medical Inc., InMode Ltd., Sciton Inc., Wells Johnson Company, Zeltiq Aesthetics Inc., Bausch Health Companies Inc., Genesis Biosystems Inc., Hologic Inc., Ambicare Clinics Pvt. Ltd., Syneron Medical Ltd., Lumenis Ltd., Cutera Inc., Erchonia Corporation, Bioventus LLC, Nordson Corp., Solta Medical a division of Bausch Health Companies Inc., BTL Industries Inc., Eclipse Aesthetics LLC, Viora Ltd., AART Infrared Systems LLC, Lutronic Corporation, I.T.E. Innowacje Technologie Edukacja Sp. z o.o., Maxillofacial Inc., Pelton & Crane Co., Redmon Group Inc., Rohde & Schwarz GmbH & Co. KG

North America was the largest region in the liposuction surgery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liposuction surgery devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liposuction surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The liposuction surgery devices market consists of sales of external ultrasound-assisted liposuction devices and stand-alone liposuction devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.